Amprius Technologies Inc(:AMPX) 
Amprius Technologies, Inc. produces and sells ultra-high energy density lithium-ion batteries for mobility applications. The company offers silicon nanowire anode batteries. Its batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as d...
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 28,536,000 | 25,234,000 | 21,426,000 | 15,067,000 | 11,284,000 | 10,631,000 | 7,855,000 | 3,345,000 | 2,336,000 | 3,944,000 | 2,798,000 | 1,632,000 | 679,000 | 792,000 | 816,000 | ||
yoy | 152.89% | 137.36% | 172.77% | 350.43% | 383.05% | 169.55% | 180.74% | 104.96% | 244.04% | 397.98% | 242.89% | ||||||
qoq | 13.09% | 17.77% | 42.20% | 33.53% | 6.14% | 35.34% | 134.83% | 43.19% | -40.77% | 40.96% | 71.45% | 140.35% | -14.27% | -2.94% | |||
cost of revenue | 22,796,000 | 19,267,000 | 18,108,000 | 13,727,000 | 13,645,000 | 12,884,000 | 12,956,000 | 9,876,000 | 6,781,000 | 7,823,000 | 7,046,000 | 4,664,000 | 4,104,000 | 2,400,000 | 2,284,000 | ||
gross profit | 5,740,000 | 5,967,000 | 3,318,000 | 1,340,000 | |||||||||||||
yoy | |||||||||||||||||
qoq | -3.80% | 79.84% | 147.61% | ||||||||||||||
gross margin % | 20.11% | 23.65% | 15.49% | 8.89% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | NaN% | NaN% |
operating expenses: | |||||||||||||||||
research and development | 3,799,000 | 2,756,000 | 2,509,000 | 2,162,000 | 2,003,000 | 2,284,000 | 1,817,000 | 1,662,000 | 1,581,000 | 1,290,000 | 815,000 | 772,000 | 800,000 | 690,000 | 488,000 | ||
selling, general and administrative | 8,628,000 | 6,157,000 | 5,501,000 | 5,991,000 | 5,307,000 | 5,359,000 | 4,335,000 | 4,739,000 | 4,293,000 | 4,575,000 | 4,068,000 | 6,279,000 | 5,526,000 | 4,349,000 | 2,367,000 | ||
total operating expenses | 12,427,000 | 31,437,000 | 8,010,000 | 8,153,000 | 7,310,000 | 9,505,000 | 6,152,000 | 6,401,000 | 5,874,000 | 5,865,000 | 4,883,000 | 7,051,000 | 6,326,000 | 5,039,000 | 2,855,000 | ||
income from operations | -6,687,000 | -25,470,000 | -4,692,000 | -6,813,000 | -9,671,000 | -11,758,000 | -11,253,000 | -12,932,000 | -10,319,000 | -9,744,000 | -9,131,000 | -10,083,000 | -9,751,000 | -6,647,000 | -4,323,000 | -1,786,154 | -114,404 |
yoy | -30.86% | 116.62% | -58.30% | -47.32% | -6.28% | 20.67% | 23.24% | 28.26% | 5.83% | 46.59% | 111.22% | 464.51% | 8423.30% | ||||
qoq | -73.75% | 442.84% | -31.13% | -29.55% | -17.75% | 4.49% | -12.98% | 25.32% | 5.90% | 6.71% | -9.44% | 3.40% | 46.70% | 53.76% | 142.03% | 1461.27% | |
operating margin % | -23.43% | -100.94% | -21.90% | -45.22% | -85.71% | -110.60% | -143.26% | -386.61% | -441.74% | -247.06% | -326.34% | -617.83% | -1436.08% | -839.27% | -529.78% | -Infinity% | -Infinity% |
other income | 1,641,000 | 385,750 | 800,000 | 443,000 | 300,000 | 312,750 | 403,000 | 415,000 | 433,000 | 480,750 | 639,000 | 635,000 | 649,000 | ||||
net income | -5,046,000 | -24,391,000 | -3,892,000 | -6,370,000 | -9,371,000 | -11,418,000 | -10,850,000 | -12,517,000 | -9,886,000 | -9,734,000 | -8,492,000 | -9,448,000 | -9,102,000 | -6,056,000 | -4,244,000 | 2,625,169 | -255,835 |
yoy | -46.15% | 113.62% | -64.13% | -49.11% | -5.21% | 17.30% | 27.77% | 32.48% | 8.61% | 60.73% | 100.09% | -459.90% | 3457.76% | ||||
qoq | -79.31% | 526.70% | -38.90% | -32.02% | -17.93% | 5.24% | -13.32% | 26.61% | 1.56% | 14.63% | -10.12% | 3.80% | 50.30% | 42.70% | -261.67% | -1126.12% | |
net income margin % | -17.68% | -96.66% | -18.16% | -42.28% | -83.05% | -107.40% | -138.13% | -374.20% | -423.20% | -246.81% | -303.50% | -578.92% | -1340.50% | -764.65% | -520.10% | Infinity% | -Infinity% |
weighted-average common shares outstanding: | |||||||||||||||||
basic and diluted | 136,947,076,000 | 124,639,991,000 | 126,630,085,000 | 121,783,506,000 | 117,969,812,000 | 101,872,347,000 | 110,408,303,000 | 97,048,734,000 | 90,029,320,000 | 86,196,391,000 | 86,354,067,000 | 85,216,827,000 | 84,645,097,000 | 71,342,720,000 | 69,013,000 | ||
net income per share | |||||||||||||||||
basic and diluted | -0.04 | -0.19 | -0.03 | -0.05 | -0.08 | -0.11 | -0.1 | -0.13 | -0.11 | -0.11 | -0.1 | -0.11 | -0.11 | -0.07 | -0.06 | ||
gross loss | -2,361,000 | -2,253,000 | -5,101,000 | -6,531,000 | -4,445,000 | -3,879,000 | -4,248,000 | -3,032,000 | -3,425,000 | -1,608,000 | -1,468,000 | ||||||
other income, net: | |||||||||||||||||
interest income and other | 591,000 | 79,000 | |||||||||||||||
gain on forgiveness of ppp loan | |||||||||||||||||
total other income | 591,000 | 79,000 | 4,411,323 | -141,431 | |||||||||||||
general and administrative expenses | 1,706,154 | 94,404 | |||||||||||||||
administrative expenses - related party | 80,000 | ||||||||||||||||
change in fair value of derivative warrant liabilities | 4,680,000 | 390,000 | |||||||||||||||
income from investments held in trust account | 294,965 | 32,549 | |||||||||||||||
offering costs associated with derivative warrant liabilities | -563,642 | -563,980 | |||||||||||||||
weighted-average shares outstanding of class a ordinary share, basic and diluted | 15,121,547 | 7,155,556 | |||||||||||||||
basic net income per share, class a ordinary share | 0.11 | ||||||||||||||||
diluted net income per share, class a ordinary share | 0.11 | ||||||||||||||||
weighted-average shares outstanding of class b ordinary share, basic | 9,416,732 | ||||||||||||||||
weighted-average shares outstanding of class b ordinary share, diluted | 9,857,142 | ||||||||||||||||
basic net income per share, class b ordinary share | 0.11 | ||||||||||||||||
diluted net income per share, class b ordinary share | 0.11 | ||||||||||||||||
administrative expenses—related party | 20,000 | ||||||||||||||||
basic and diluted net loss per share, class a ordinary share | -0.02 | ||||||||||||||||
weighted-average shares outstanding of class b ordinary share, basic and diluted | 8,971,428 | ||||||||||||||||
basic and diluted net loss per share, class b ordinary share | -0.02 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||
current assets: | |||||||||||||||||
cash and cash equivalents | 62,352,000 | 90,465,000 | 73,224,000 | 54,189,000 | 48,417,000 | 55,155,000 | 35,045,000 | 46,447,000 | 39,045,000 | 45,761,000 | 53,396,000 | 65,010,000 | 64,187,000 | 69,696,000 | 73,803,000 | ||
accounts receivable | 35,261,000 | 23,737,000 | 21,917,000 | 10,766,000 | 10,396,000 | 5,580,000 | 4,590,000 | 1,738,000 | 1,442,000 | 1,265,000 | 1,887,000 | 1,130,000 | 555,000 | 686,000 | 782,000 | ||
inventories | 8,246,000 | 6,735,000 | 4,679,000 | 4,335,000 | 4,003,000 | 6,574,000 | 2,664,000 | 1,527,000 | 858,000 | 730,000 | 487,000 | 503,000 | 845,000 | 500,000 | 503,000 | ||
prepaid expenses and other current assets | 8,095,000 | 5,500,000 | 6,884,000 | 2,564,000 | 3,307,000 | 1,454,000 | 2,641,000 | 2,172,000 | 3,351,000 | 1,987,000 | 2,738,000 | 1,479,000 | 1,841,000 | 2,394,000 | 2,319,000 | ||
total current assets | 113,954,000 | 126,437,000 | 106,704,000 | 71,854,000 | 66,123,000 | 68,763,000 | 44,940,000 | 53,043,000 | 45,623,000 | 50,522,000 | 61,394,000 | 70,700,000 | 69,903,000 | 75,173,000 | 77,819,000 | 2,189,769 | 3,000,981 |
non-current assets: | |||||||||||||||||
property, plant and equipment | 10,746,000 | 9,680,000 | 16,334,000 | 17,275,000 | 17,950,000 | 17,481,000 | 23,968,000 | 23,949,000 | 22,938,000 | 21,760,000 | 16,673,000 | 6,903,000 | 4,948,000 | 4,236,000 | |||
operating lease right-of-use assets | 6,022,000 | 19,518,000 | 32,178,000 | 32,623,000 | 33,067,000 | 33,512,000 | 33,829,000 | 34,291,000 | 34,660,000 | 35,149,000 | 7,591,000 | 7,744,000 | 7,894,000 | 2,751,000 | |||
other assets | 62,000 | 1,256,000 | 1,256,000 | 1,289,000 | 1,332,000 | 1,369,000 | 1,470,000 | 1,476,000 | 1,466,000 | 305,000 | 957,000 | 702,000 | 684,000 | 644,000 | 604,000 | ||
total assets | 130,784,000 | 156,891,000 | 156,472,000 | 123,041,000 | 118,472,000 | 121,125,000 | 104,207,000 | 112,759,000 | 104,687,000 | 107,736,000 | 86,615,000 | 86,637,000 | 83,948,000 | 83,171,000 | 86,502,000 | 232,593,001 | 233,033,530 |
liabilities and stockholders’ equity | |||||||||||||||||
current liabilities: | |||||||||||||||||
accounts payable | 8,882,000 | 6,700,000 | 7,843,000 | 3,739,000 | 6,225,000 | 7,424,000 | 4,934,000 | 4,490,000 | 1,992,000 | 3,341,000 | 3,578,000 | 597,000 | 1,023,000 | 1,028,000 | 2,641,000 | 29,673 | 71,138 |
accrued and other current liabilities | 3,170,000 | 3,666,000 | 4,291,000 | 4,075,000 | 2,321,000 | 4,832,000 | 4,196,000 | 3,269,000 | 3,431,000 | 5,594,000 | 5,649,000 | 7,141,000 | 3,665,000 | 2,708,000 | 2,183,000 | ||
deferred grant | 2,738,000 | 2,738,000 | 2,738,000 | ||||||||||||||
deferred revenue | 18,000 | 100,000 | 705,000 | 840,000 | 1,778,000 | 1,638,000 | 1,817,000 | 3,151,000 | 3,243,000 | 3,434,000 | 3,569,000 | 3,198,000 | 3,135,000 | 2,660,000 | 795,000 | ||
operating lease liabilities | 1,173,000 | 4,665,000 | 3,215,000 | 3,425,000 | 3,636,000 | 3,316,000 | 2,053,000 | 1,916,000 | 1,096,000 | 1,088,000 | 1,079,000 | 1,070,000 | 1,061,000 | 521,000 | 517,000 | ||
total current liabilities | 15,981,000 | 17,869,000 | 16,054,000 | 12,079,000 | 13,960,000 | 17,210,000 | 13,000,000 | 12,826,000 | 9,762,000 | 13,457,000 | 13,875,000 | 12,006,000 | 8,884,000 | 6,917,000 | 6,136,000 | 1,184,046 | 220,241 |
non-current liabilities: | |||||||||||||||||
total liabilities | 21,370,000 | 53,076,000 | 53,280,000 | 46,387,000 | 48,076,000 | 51,653,000 | 48,208,000 | 47,630,000 | 44,752,000 | 47,936,000 | 20,859,000 | 19,947,000 | 16,913,000 | 10,138,000 | 10,500,000 | 20,744,046 | 24,070,241 |
commitments and contingencies | |||||||||||||||||
stockholders’ equity: | |||||||||||||||||
preferred stock; 0.0001 par value... | |||||||||||||||||
common stock; 0.0001 par value... | 13,000 | 13,000 | 13,000 | 13,000 | 12,000 | 12,000 | 11,000 | 11,000 | 9,000 | 9,000 | 9,000 | 9,000 | 8,000 | 8,000 | |||
additional paid-in capital | 332,795,000 | 322,156,000 | 297,149,000 | 266,723,000 | 254,093,000 | 243,794,000 | 218,904,000 | 217,184,000 | 199,475,000 | 189,454,000 | 185,676,000 | 178,118,000 | 169,016,000 | 165,912,000 | 162,825,000 | ||
accumulated other comprehensive income | 10,000 | 4,000 | |||||||||||||||
accumulated deficit | -223,404,000 | -218,358,000 | -193,967,000 | -190,075,000 | -183,705,000 | -174,334,000 | -162,916,000 | -152,066,000 | -139,549,000 | -129,663,000 | -119,929,000 | -111,437,000 | -101,989,000 | -92,887,000 | -86,831,000 | -18,346,930 | -21,037,697 |
total stockholders’ equity | 109,414,000 | 103,815,000 | 103,192,000 | 76,654,000 | 70,396,000 | 69,472,000 | 55,999,000 | 65,129,000 | 59,935,000 | 59,800,000 | 65,756,000 | 66,690,000 | 67,035,000 | 73,033,000 | 76,002,000 | ||
total liabilities and stockholders’ equity | 130,784,000 | 156,891,000 | 156,472,000 | 123,041,000 | 118,472,000 | 121,125,000 | 104,207,000 | 112,759,000 | 104,687,000 | 107,736,000 | 86,615,000 | 86,637,000 | 83,948,000 | 83,171,000 | 86,502,000 | ||
accumulated other comprehensive loss | -3,000 | -7,000 | -4,000 | ||||||||||||||
deferred costs | 1,159,000 | 927,000 | 779,000 | 2,886,000 | 2,578,000 | 2,475,000 | 1,897,000 | 412,000 | |||||||||
operating lease right-of-use asset | 2,830,000 | ||||||||||||||||
property and equipment | 3,824,000 | ||||||||||||||||
common stock, 0.0001 par value... | 8,000 | ||||||||||||||||
cash | 1,966,389 | 2,650,976 | |||||||||||||||
prepaid expenses | 223,380 | 350,005 | |||||||||||||||
prepaid expenses - long-term | 108,333 | ||||||||||||||||
investments held in trust account | 230,294,899 | 230,032,549 | |||||||||||||||
offering costs associated with initial public offering | |||||||||||||||||
liabilities, class a ordinary shares subject to possible redemption and shareholders’ deficit | |||||||||||||||||
accrued expenses | 1,154,373 | 149,103 | |||||||||||||||
note payable - related party | |||||||||||||||||
derivative warrant liabilities | 11,310,000 | 15,600,000 | |||||||||||||||
deferred underwriting fees | 8,050,000 | 8,050,000 | |||||||||||||||
working capital loan - related party | 200,000 | ||||||||||||||||
class a ordinary shares subject to possible redemption; 23,000,000 and -0- shares at redemption value of 10.008 and 10.000 per share at june 30, 2022 and december 31, 2021, respectively | 230,194,899 | ||||||||||||||||
shareholders’ deficit: | |||||||||||||||||
preference shares, 0.0001 par value... | |||||||||||||||||
class a ordinary shares, 0.0001 par value... | |||||||||||||||||
class b ordinary shares, 0.0001 par value... | 986 | 986 | |||||||||||||||
total shareholders’ deficit | -18,345,944 | -21,036,711 | |||||||||||||||
total liabilities, class a ordinary shares subject to possible redemption and shareholders’ deficit | 232,593,001 | 233,033,530 | |||||||||||||||
note payable—related party | |||||||||||||||||
working capital loan—related party | 200,000 | ||||||||||||||||
class a ordinary shares subject to possible redemption; 23,000,000 and -0- shares at redemption value of 10.00 per share at march 31, 2022 and december 31, 2021 | 230,000,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||
net loss | -5,046,000 | -24,391,000 | -3,892,000 | -6,370,000 | -9,371,000 | -11,418,000 | -10,850,000 | -12,517,000 | -9,886,000 | -9,734,000 | -8,492,000 | -9,448,000 | -9,102,000 | -6,056,000 | -255,835 | ||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||
stock-based compensation | 2,058,000 | 1,919,000 | 1,763,000 | 1,906,000 | 1,822,000 | 2,435,000 | 1,720,000 | 1,941,000 | 1,247,000 | 1,115,000 | 1,115,000 | 924,000 | 726,000 | 586,000 | |||
depreciation and amortization | 761,000 | 1,224,000 | 1,181,000 | 1,018,000 | 943,000 | 891,000 | 864,000 | 1,036,000 | 1,017,000 | 488,000 | 462,000 | 440,000 | 416,000 | 423,000 | |||
loss on termination of lease | 166,000 | ||||||||||||||||
write-down of property, plant and equipment | 77,000 | ||||||||||||||||
non-cash operating lease expense | 619,000 | 1,286,000 | 1,286,000 | 1,285,000 | 1,286,000 | 1,286,000 | 1,286,000 | 1,285,000 | 1,286,000 | 337,000 | 305,000 | 304,000 | 202,000 | 139,000 | |||
gain on disposal of property, plant and equipment | -355,000 | ||||||||||||||||
other non-cash items | -22,000 | 10,000 | -374,000 | 543,000 | 275,000 | ||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||
accounts receivable | -11,489,000 | -1,828,000 | -10,776,000 | -913,000 | -5,092,000 | -990,000 | -2,852,000 | -296,000 | -177,000 | 622,000 | -757,000 | -575,000 | 131,000 | 96,000 | |||
inventories | -1,511,000 | -2,056,000 | -345,000 | -331,000 | 2,571,000 | -3,910,000 | -1,137,000 | -669,000 | -128,000 | -243,000 | 16,000 | 342,000 | -345,000 | ||||
prepaid expenses and other current assets | -2,621,000 | -1,351,000 | -1,584,000 | 742,000 | -1,653,000 | 1,187,000 | -469,000 | 534,000 | -719,000 | 306,000 | -814,000 | 362,000 | 553,000 | -76,000 | |||
other assets | 13,000 | 2,000 | 6,000 | 10,000 | 10,000 | -11,000 | 6,000 | -21,000 | 9,000 | 0 | 0 | ||||||
accounts payable | 1,649,000 | -1,465,000 | 4,276,000 | -2,112,000 | -1,697,000 | 2,597,000 | 1,226,000 | 1,709,000 | 352,000 | -610,000 | 1,531,000 | -364,000 | 59,000 | -1,758,000 | 2,258,955 | -41,465 | 57,510 |
accrued and other current liabilities | -898,000 | -632,000 | 220,000 | 1,754,000 | -2,512,000 | 636,000 | 1,135,000 | -355,000 | -2,163,000 | 757,000 | -1,595,000 | 2,783,000 | 1,120,000 | 730,000 | |||
deferred revenue | -82,000 | -605,000 | -135,000 | -938,000 | 140,000 | -179,000 | -1,334,000 | -92,000 | -191,000 | -252,000 | -455,000 | 104,000 | 657,000 | 798,000 | |||
operating lease liabilities | -20,594,000 | -872,000 | -872,000 | -859,000 | -848,000 | -471,000 | -283,000 | -282,000 | -278,000 | -274,000 | -274,000 | -274,000 | -179,000 | -132,000 | |||
net cash from operating activities | -37,275,000 | -3,497,000 | -9,246,000 | -4,265,000 | -14,126,000 | -6,085,000 | -9,529,000 | -7,959,000 | -9,779,000 | -4,800,000 | -8,678,000 | -5,583,000 | -6,492,000 | -5,698,000 | -7,206,933 | -563,587 | -413,480 |
capital expenditures | 267,000 | -2,357,000 | -414,000 | -716,000 | -367,000 | 3,520,000 | -1,333,000 | -1,605,000 | -3,896,000 | -5,751,000 | -8,931,000 | -1,728,000 | -1,140,000 | 0 | 0 | 0 | 0 |
free cash flows | -37,008,000 | -5,854,000 | -9,660,000 | -4,981,000 | -14,493,000 | -2,565,000 | -10,862,000 | -9,564,000 | -13,675,000 | -10,551,000 | -17,609,000 | -7,311,000 | -7,632,000 | -5,698,000 | -7,206,933 | -563,587 | -413,480 |
cash flows from investing activities: | |||||||||||||||||
purchase of property, plant and equipment | -980,000 | -2,357,000 | -414,000 | -716,000 | -913,000 | 3,627,000 | -1,333,000 | -1,605,000 | -3,896,000 | -5,751,000 | -8,931,000 | -1,728,000 | -1,140,000 | ||||
proceeds from the disposal of property, plant and equipment | 355,000 | ||||||||||||||||
net cash from investing activities | -625,000 | -2,357,000 | -414,000 | -716,000 | -913,000 | 3,627,000 | -1,333,000 | -1,605,000 | -3,896,000 | -5,751,000 | -8,931,000 | -1,728,000 | -1,140,000 | -734,000 | 229,253,000 | 0 | -230,000,000 |
cash flows from financing activities: | |||||||||||||||||
proceeds from issuance of common stock in connection with the at market issuance sales agreement | 19,615,000 | 25,858,000 | 9,738,000 | 8,457,000 | 22,555,000 | 0 | 2,730,000 | 8,131,000 | |||||||||
proceeds from exercise of warrants | 1,895,000 | ||||||||||||||||
proceeds from exercise of stock options | 6,686,000 | 1,172,000 | 2,833,000 | 1,018,000 | 48,000 | 13,000 | 0 | 68,000 | 28,000 | 195,000 | 112,000 | 1,000 | 2,000 | 36,000 | |||
net cash from financing activities | 8,581,000 | 23,088,000 | 28,691,000 | 10,756,000 | 8,505,000 | 22,568,000 | -540,000 | 16,966,000 | 8,159,000 | 2,916,000 | 5,995,000 | 8,134,000 | 2,123,000 | 2,048,000 | -161,288,305 | -121,000 | 232,987,305 |
net decrease in cash, cash equivalents and restricted cash equivalents | -29,319,000 | -6,534,000 | -5,516,000 | ||||||||||||||
effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | 6,000 | 7,000 | 4,000 | -3,000 | -4,000 | ||||||||||||
cash, cash equivalents and restricted cash equivalents, beginning of period | 91,921,000 | 0 | 0 | 56,411,000 | 0 | 0 | 45,817,000 | ||||||||||
cash, cash equivalents and restricted cash equivalents, end of period | 62,608,000 | 19,035,000 | 5,772,000 | 49,873,000 | -11,402,000 | 7,402,000 | 40,301,000 | ||||||||||
reconciliation of cash, cash equivalents and restricted cash equivalents shown on the condensed consolidated balance sheets: | |||||||||||||||||
cash and cash equivalents | 62,352,000 | 17,241,000 | 19,035,000 | 5,772,000 | 48,417,000 | 20,110,000 | -11,402,000 | 7,402,000 | 39,045,000 | -7,635,000 | -11,614,000 | 823,000 | 64,187,000 | -4,107,000 | |||
restricted cash equivalents included in prepaid expenses and other current assets | 200,000 | 0 | 0 | 0 | 200,000 | ||||||||||||
restricted cash equivalents included in other assets | 56,000 | 0 | 0 | 0 | 1,256,000 | 0 | 0 | 0 | 1,256,000 | ||||||||
total cash, cash equivalents and restricted cash equivalents | 62,608,000 | 17,241,000 | 19,035,000 | 5,772,000 | 49,873,000 | 20,110,000 | -11,402,000 | 7,402,000 | 40,301,000 | ||||||||
supplemental non-cash investing and financing activities: | |||||||||||||||||
unpaid purchases of property, plant and equipment | 1,247,000 | 546,000 | -107,000 | ||||||||||||||
right-of-use asset and operating lease obligations from new lease | 105,000 | ||||||||||||||||
right-of-use assets derecognized in connection with lease termination | 13,362,000 | ||||||||||||||||
amortization of deferred costs | 0 | 1,987,000 | 668,000 | 268,000 | 134,000 | ||||||||||||
impairment and other | |||||||||||||||||
deferred costs | 0 | -87,000 | -232,000 | -148,000 | 120,000 | -388,000 | -440,000 | -864,000 | -2,012,000 | ||||||||
deferred grant | |||||||||||||||||
proceeds from issuance of common stock upon exercise of stock warrants | 0 | 0 | |||||||||||||||
payment of equity financing costs | 0 | -540,000 | |||||||||||||||
net increase in cash, cash equivalents and restricted cash equivalents | 17,234,000 | 19,031,000 | |||||||||||||||
cash, cash equivalents and restricted cash equivalents, beginning of year | |||||||||||||||||
cash, cash equivalents and restricted cash equivalents, end of year | |||||||||||||||||
reconciliation of cash, cash equivalents and restricted cash equivalents shown on the consolidated balance sheets: | |||||||||||||||||
increase in fair value of modified stock warrants | 0 | ||||||||||||||||
cancellation and retirement of common stock | |||||||||||||||||
loss on retirement of property, plant and equipment | |||||||||||||||||
loss on write-off of deferred stock issuance costs | |||||||||||||||||
proceeds from issuance of common stock in connection with the stock purchase agreement | |||||||||||||||||
unpaid financing costs from the issuance of shares of common stock | |||||||||||||||||
payment of financing costs in connection with the stock purchase and at market issuance sales agreements | |||||||||||||||||
proceeds from issuance of common stock in connection with business combination and pipe investment | |||||||||||||||||
payment of transaction and issuance costs in connection with business combination and pipe investment | |||||||||||||||||
proceeds from exercise of stock warrants | 0 | 0 | |||||||||||||||
capital contributions from amprius holdings | 0 | ||||||||||||||||
net increase in cash, cash equivalents and restricted cash | -7,635,000 | ||||||||||||||||
cash, cash equivalents and restricted cash, beginning of year | |||||||||||||||||
cash, cash equivalents and restricted cash, end of year | |||||||||||||||||
components of cash, cash equivalents and restricted cash: | |||||||||||||||||
restricted cash included in other assets | 0 | 0 | 0 | 56,000 | -277,000 | ||||||||||||
total cash, cash equivalents and restricted cash | -7,635,000 | -11,614,000 | 823,000 | 64,243,000 | |||||||||||||
supplemental disclosure of non-cash investing and financing information: | |||||||||||||||||
unpaid financing costs in connection with a stock purchase agreement | |||||||||||||||||
proceeds from issuance of common stock in connection with a stock purchase agreement | |||||||||||||||||
payments of financing costs | |||||||||||||||||
cash, cash equivalents and restricted cash, beginning of period | 0 | 0 | 69,752,000 | ||||||||||||||
cash, cash equivalents and restricted cash, end of period | -11,614,000 | 823,000 | 64,243,000 | ||||||||||||||
reconciliation of cash, cash equivalents and restricted cash shown on the condensed consolidated balance sheets: | |||||||||||||||||
issuance of common stock in connection with a stock purchase agreement | 8,118,000 | 2,389,000 | |||||||||||||||
payment of financing costs in connection with a stock purchase agreement | 14,000 | -268,000 | |||||||||||||||
net decrease in cash, cash equivalents and restricted cash | 823,000 | -5,509,000 | |||||||||||||||
loss from disposal of property, plant and equipment | |||||||||||||||||
gain on forgiveness of ppp loan | |||||||||||||||||
operating lease liabilities and right-of-use assets upon adoption of asc 842 | |||||||||||||||||
gain on forgiveness of ppp loan and other | |||||||||||||||||
purchase of property and equipment | |||||||||||||||||
proceeds from issuance of common stock in connection with business combination and pipe investment, net of issuance costs | |||||||||||||||||
payment of costs in connection with a stock purchase agreement | |||||||||||||||||
net increase in cash and cash equivalents | |||||||||||||||||
cash, cash equivalents, and restricted cash, beginning of period | |||||||||||||||||
cash, cash equivalents, and restricted cash, end of period | |||||||||||||||||
components of cash, cash equivalents, and restricted cash: | |||||||||||||||||
total cash, cash equivalents, and restricted cash | |||||||||||||||||
net income | |||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||
general and administrative expenses paid by related party in exchange for issuance of class b ordinary shares | |||||||||||||||||
change in fair value of derivative warrant liabilities | -4,290,000 | -390,000 | |||||||||||||||
offering costs associated with derivative warrant liabilities | -338 | 563,980 | |||||||||||||||
income from investments held in trust account | -262,350 | -32,549 | |||||||||||||||
prepaid expenses | 18,292 | -350,005 | |||||||||||||||
accrued expenses | 1,131,270 | -6,581 | |||||||||||||||
cash flows from investing activities | |||||||||||||||||
cash deposited in trust account | 0 | -230,000,000 | |||||||||||||||
proceeds received from initial public offering, gross | 0 | 230,000,000 | |||||||||||||||
proceeds received from private placement | 0 | 8,000,000 | |||||||||||||||
offering costs paid | -121,000 | -5,012,695 | |||||||||||||||
net change in cash | -684,587 | 2,573,825 | |||||||||||||||
cash - beginning of the period | |||||||||||||||||
cash - end of the period | |||||||||||||||||
supplemental disclosure of non-cash financing activities: | |||||||||||||||||
offering costs included in accounts payable | |||||||||||||||||
offering costs included in accrued expenses | 126,000 | ||||||||||||||||
deferred underwriting commissions | 0 | 8,050,000 | |||||||||||||||
remeasurement of class a ordinary shares subject to possible redemption | |||||||||||||||||
cash—beginning of the period | 77,151 | ||||||||||||||||
cash—end of the period | 2,650,976 |